The FDA has rejected a biologics license application for apitegromab to treat spinal muscular atrophy, according to manufacturer Scholar Rock.

Many people think ISAs are complicated, and that perception isn't helped by the maze of options out there. But ISAs are simply accounts for your savings or investments that are tax-free forever. This ...